Anavex Life Sciences Corp (AVXL)

[Joseph_K]

To me the evidence is too skimpy to say the P2b/3 efficacy results were "best in class" (though I agree regarding safety results). I'm good with us agreeing to disagree: Neither of us is going to convince the other until Anavex provides substantially more data and analysis of the trial results or at least the initial protocol or statistical analysis plan ... at which point which of us had been right really won't matter much to either of us!

As for Rikker and shorts, I just don't see this message board as influencing share price significantly ever, and certainly not in the medium- or long-term. As a result, I don't worry about it. I'd rather use the board to develop my own thoughts and learn things.